Literature DB >> 28571100

Diagnosis and New Treatment Avenues in Spinal Muscular Atrophy.

Astrid Pechmann1, Janbernd Kirschner1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28571100     DOI： 10.1055/s-0037-1603517

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN： 0174-304X            Impact factor:   1.947


× No keyword cloud information.
  5 in total

Review 1.  Treatment Advances in Spinal Muscular Atrophy.

Authors:  Diana Bharucha-Goebel; Petra Kaufmann
Journal:  Curr Neurol Neurosci Rep       Date:  2017-10-06       Impact factor: 5.081

2.  Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany.

Authors:  Astrid Pechmann; Thorsten Langer; David Schorling; Sabine Stein; Sibylle Vogt; Ulrike Schara; Heike Kölbel; Oliver Schwartz; Andreas Hahn; Kerstin Giese; Jessika Johannsen; Jonas Denecke; Claudia Weiß; Manuela Theophil; Janbernd Kirschner
Journal:  J Neuromuscul Dis       Date:  2018

3.  Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care.

Authors:  David C Schorling; Astrid Pechmann; Janbernd Kirschner
Journal:  J Neuromuscul Dis       Date:  2020

Review 4.  New Therapeutics Options for Pediatric Neuromuscular Disorders.

Authors:  Marina Flotats-Bastardas; Andreas Hahn
Journal:  Front Pediatr       Date:  2020-11-23       Impact factor: 3.418

5.  Position Statement: Sharing of Clinical Research Data in Spinal Muscular Atrophy to Accelerate Research and Improve Outcomes for Patients.

Authors:  Hanns Lochmüller; David Evans; Wildon Farwell; Richard Finkel; Nathalie Goemans; Mencia de Lemus; Vitaliy Matyushenko; Francesco Muntoni; Marie-Christine Ouillade; Inge Schwersenz; Petra Wilson
Journal:  J Neuromuscul Dis       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.